CaliPharms Profit Margin

CaliPharms posts a profit margin of -56.78% as of September 2014. That is below the Industrials sector average of 10.05%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Industrials stocks, a profit margin near 10.05% is typical. CaliPharms's -56.78% is lower that level. That is roughly 56620.7% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

CaliPharms's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -56.78% as of September 2014; use YoY and peer views to separate noise from signal.

Context for KGET's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.05%), and (3) consistency with growth and profitability. This page covers the first two; CaliPharms's other metric pages and overview cover the third.

Judging CaliPharms against Industrials peers is usually better than using a market-wide rule of thumb. Business models inside Industrials are more comparable, which makes gaps in profit margin easier to interpret. Start with -56.78% here, then scan peer and history charts to see if the gap is persistent.